J M Nesland Selected Research

Carcinoma (Carcinomatosis)

01/2004	Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
01/2004	The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas.
06/2003	Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
05/2003	Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
12/2001	Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
12/2001	Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
11/2001	Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
11/2001	Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
11/2001	Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
07/2001	Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.
07/2001	Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study.
07/2001	Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas.
05/2001	Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study.
04/2001	Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
03/2001	Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
12/2000	E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
12/2000	E-Cadherin complex protein expression and survival in ovarian carcinoma.
09/2000	Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
04/2000	Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
03/2000	Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.

Articles by Research Topic

Disease

20	Carcinoma (Carcinomatosis) 01/2004 - 03/2000
5	Neoplasms (Cancer) 01/2007 - 09/2000
3	Breast Neoplasms (Breast Cancer) 11/2002 - 01/2000
2	Melanoma (Melanoma, Malignant) 12/2001 - 09/2000
2	Ovarian Neoplasms (Ovarian Cancer) 11/2000 - 03/2000
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2007
1	Adenocarcinoma 05/2005
1	Glioma (Gliomas) 01/2003
1	Synovial Sarcoma (Synovioma) 05/2002
1	Colorectal Neoplasms (Colorectal Cancer) 11/2001
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2001
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2001
1	Phototoxic Dermatitis (Phototoxicity) 08/2001
1	Lobular Carcinoma 01/2001
1	Neoplasm Metastasis (Metastasis) 04/2000

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 01/2004 - 03/2001
4	Cyclin AIBA 05/2003 - 07/2001
4	Cadherins (E-Cadherin)IBA 11/2002 - 01/2000
3	beta CateninIBA 11/2002 - 01/2000
3	AntigensIBA 11/2001 - 04/2000
2	gamma Catenin (Plakoglobin)IBA 12/2000 - 01/2000
2	Cyclin D1IBA 09/2000 - 03/2000
1	5-aminolevulinic acid hexyl esterIBA 04/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2007
1	CyclinsIBA 05/2005
1	Epidermal Growth Factor Receptor (EGF Receptor)IBA 01/2004
1	Thymidine PhosphorylaseIBA 01/2004
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2004
1	Thymidylate SynthaseIBA 01/2004
1	Plasminogen Activator Inhibitor 1IBA 01/2003
1	Keratins (Keratin)IBA 05/2002
1	VimentinIBA 05/2002
1	Integrin alphaVIBA 12/2001
1	PeptidesIBA 11/2001
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2001
1	Tissue Inhibitor of Metalloproteinase-2IBA 11/2001
1	Cell Cycle ProteinsIBA 11/2001
1	methyl 5-aminolevulinateIBA 09/2001
1	PorphyrinsIBA 09/2001
1	HormonesIBA 09/2001
1	protoporphyrin IXIBA 08/2001
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 08/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2001
1	Estrogen Receptor alphaIBA 07/2001
1	Caveolin 1IBA 05/2001
1	Matrix MetalloproteinasesIBA 04/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Proteins (Proteins, Gene)IBA 11/2000
1	cyclin D3IBA 09/2000
1	sialosyl-Tn antigenIBA 09/2000
1	P-GlycoproteinIBA 03/2000
1	alpha Catenin (alpha E-Catenin)IBA 01/2000

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 08/2001
1	Heterologous Transplantation (Xenotransplantation) 08/2001
1	Drug Therapy (Chemotherapy) 03/2000